| Literature DB >> 32682505 |
Tailyne Zortéa1, Daniele Paola da Silva Wizbicki2, Kristian Madeira3, Pedro Gabriel Ambrosio2, Rafaela Okchstein Borges de Souza2, Edson Souza Machado Durães4.
Abstract
BACKGROUND AND OBJECTIVES: The measurement of Hb by co-oximetry is an innovative technique that offers efficiency and agility in the processing of information regarding the measurement of Hemoglobin concentration (Hb) obtained through continuous, non-invasive and rapid monitoring. Because of this attribute, it avoids unnecessary exposures of the patient to invasive procedures by allowing a reduction in the number of blood samples for evaluation and other unnecessary therapies. It also helps to make decisions about the need for transfusion and how to handle it. The objective of this study is to compare the performance offered to obtain Hb values between the Masimo Corporation (Irvine, CA, USA) instrument and the standard gold tool (laboratory examination). CONTENTS: The study corresponds to a systematic review followed by meta-analysis, which included fully registered full-text clinical trials published from 1990 to 2018. PubMed, Cochrane, Medline, Embase and Web of Science databases were investigated. The mean overall difference found between the non-invasive and invasive methods of hemoglobin monitoring was 0.23 (95% CI -0.16, 0.62), that is, it did not present statistical significance (p = 0.250). The results of the analysis of heterogeneity within and between the studies indicated high levels of inconsistency (Q = 461.63, p < 0.0001, I2 = 98%), method for Hb values.Entities:
Keywords: Análise química do sangue; Blood chemical analysis; Blood gas monitoring transcutaneous; Clinical trial; Ensaio clínico; Espectrofotometria; Metanálise; Meta‐analysis; Monitorização transcutânea dos gases sanguíneos; Oximetria; Oximetry; Revisão sistemática; Spectrophotometry; Systematic review
Mesh:
Substances:
Year: 2020 PMID: 32682505 PMCID: PMC9373349 DOI: 10.1016/j.bjan.2019.05.006
Source DB: PubMed Journal: Braz J Anesthesiol ISSN: 0104-0014
Figure 1Flowchart of article selection process. Source: Research data, 2018.
Characteristics of studies included in the meta-analysis on comparison of the invasive (laboratory) and non-invasive (pulse CO-oximetry) methods to measure Hb.
| Author | Year | Country | Population characteristics | Age (mean ± sd), mean (range) or median (range) | Sex | Device tested (version of software, version of sensor) | Hb laboratory analysis | Size of sample/number of paired measurements | Subgroups (size of sample/number of paired measurements) | Device tested | Laboratory analysis | SMD | SD |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bergek C, Zdolsek JH, Hahn RG | 2012 | Sweden | Study volunteers, fluid infusion | 22 (18–28) | Male 100% | Radical-7 (7.6.0.1, A single use adhesive sensor type R2–25a) | Beckman Coulter AcT-5 diff | 10/956 | NR | NR | −0.07 | 1.17 | |
| Butwick A, Hilton G, Carvalho B | 2011 | US | Elective C-section | 32 (5) | Female 100% | Radical-7 (7.6.0.4, Sensor Rev E) | Coulter LH 750 or LH 780 or CELLDYN Sapphire o CELL-DYN 1800 | 50/150 | Baseline (50/50) | NR | NR | 1.22 | 1.08 |
| Gayat E et al. | 2012 | US | Emergency Department | 57 (43–75) | Male 51.5% | Masimo Pronto-7 (version 2.1.9, Masimo, Sensor Rainbow 4D DC) | ADVIA 2120 | 272/272 | Abdominal pain (21%), Chest pain (13%), dyspnea (12%), sepsis (8%) and bleeding (7%). | NR | 13.2 (11.9–14.3) | 0.56 | 1.21 |
| Hahn RG, Li Y, Zdolsek J | 2010 | Sweden | Study volunteers, fluid infusion | 22 (19–37) | Male 100% | Radical-7 (7.4.0.9, Sensor handheld R.7.7.1.0, D-station R5.1.2.7) | Cell-Dyn Sapphire | 10/680 | Group 1: hydrated volunteers, received 5 mL.kg−1 of Ringer acetate in 15 min. (10/167); | 13.425 (0.998) | 13.368 (0.862) | −0.37 | 1.03 |
| Group 2: dehydrated volunteers, received 5 mL.kg−1 of Ringer acetate in 15 min. (10/187); | |||||||||||||
| Group 3: hydrated volunteers, received 10 mL.kg−1 of Ringer acetate in 15 min. (10/168); | |||||||||||||
| Group 4: dehydrated volunteers, received 10 mL.kg−1 of Ringer acetate in 15 min. (10/158). | |||||||||||||
| Khalafallah AA et al. | 2014 | Australia | Elective Surgery | Male 65.6 (12)/ Female 61.1 (14.9) | Male 50.34% | Masimo Pronto-7 (version 2.1.9, Masimo Corporation, Rainbow 4D Sensor | Sysmex XE-5000 | 584/584 | Pre-operative: 638 pre-assessment with expectation of normal Hb and 88 oncological patients with expectation of reduced Hb. | NR | NR | −0.71 | 1.30 |
| Park YH et al. | 2012 | South Korea | Neurosurgery, pediatrics | 6.4 ± 3.0 | Male 62.5% | Radical-7 (7.6.1.1, Sensor Rev E) | ABL820 | 40/119 | After volume replenishment (NR/47); after administration of colloid (NR/32); after red blood cell replenishment (NR/15); tHb < 9 (NR/NR); 9 ≤ tHb < 11 (NR/NR); 11 ≤ tHb (NR/NR). | NR | NR | 0.9 | 1.35 |
| Tsuei BJ et al. | 2014 | US | Surgical ICU | > 18 | Male 60% | Radical-7 (NR, NR) | iSTAT Abbott Point of Care and CBC LH 780 | 88/572 | CBC | NR | 1.49 | 1.76 | |
| Vos JJ et al. | 2012 | Netherlands | Liver resection | 56 (19–76) | Male 27% | Radical-7 (7.6.0.1, Sensor R2-25, Rev E) | ABL 800 | 15/335 | Crystalloid infusion (15/335) | NR | NR | −0.27 | 1.06 |
Hb (Mean ± SD), Mean (Range) or Median (Range).
SMD, Standardized Means Difference; SD, Standard Deviation; NR, Not Reported.
Source: Research Data, 2018.
Figure 2Overall analysis forest chart. Source: Research data, 2018.
Figure 3QUADAS-2 chart of results per study. Source: Research data, 2018.
Figure 4Subgroup forest chart (elective status patients). Source: Research Data, 2018.
Figure 5Subgroup forest chart (non-elective status patients). Source: Research data, 2018.
Figure 6Subgroup forest chart (age). Source: Research data, 2018.
Figure 7Subgroup forest chart (both sexes). Source: Research data, 2018.
Figure 8Subgroup forest chart (country). Source: Research data, 2018.
Figure 9Funnel chart. Source: Research data, 2018.